Article
Palo Alto, Calif. - Connetics Corp., based here, plans to start clinicaltrials on a new acne drug that some reports say is "cosmetically elegant."
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.